Clinical trial
A Pilot Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism
NCT06867913 is registered in ClinicalTrials.gov with S.LAB (SOLOWAYS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism
- Lead sponsor
- S.LAB (SOLOWAYS)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 15, 2024
- Completion date
- February 21, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune thyroiditis